Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals, page-83

If the current results continue I have no doubt that the FDA will give fast track approval. I think the bigger picture warrants that given the current prolonged standard of care is a significant burden on health care infrastructure which is already buckling under the strain in most countries. To be able to free up those resources will provide far reaching heath care outcomes and economic value to society. The ability to maintain quality of life and productivity of an individual under treatment will relieve a huge burden on patients and their families as well as the community as a whole. A successful outcome has so many positive flow on effects. Great results and continued appreciation goes out to the IMU team who strive tirelessly to deliver these outcomes.